FDA panel votes against approving Intellipharma's opioid painkiller
Reuters: Health News
(Reuters) - A panel of independent advisers to the U.S. Food and Drug Administration overwhelmingly concluded on Wednesday that there is not enough evidence to support approval of Intellipharmaceutics International Inc's long-acting opioid painkiller.
NYT > Health
For the first time this year, health officials have documented a case of local mosquito transmission of the virus within the contiguous United States.
The legislative showdown will continue Wednesday as the Senate considers various measures to replace the health law.
Dog owners spent 30 fewer minutes a day being sedentary than those who didn’t own a dog.
No comments:
Post a Comment